PLoS ONE (Jan 2013)

Vaccination to conserved influenza antigens in mice using a novel Simian adenovirus vector, PanAd3, derived from the bonobo Pan paniscus.

  • Alessandra Vitelli,
  • Mary R Quirion,
  • Chia-Yun Lo,
  • Julia A Misplon,
  • Agnieszka K Grabowska,
  • Angiolo Pierantoni,
  • Virginia Ammendola,
  • Graeme E Price,
  • Mark R Soboleski,
  • Riccardo Cortese,
  • Stefano Colloca,
  • Alfredo Nicosia,
  • Suzanne L Epstein

DOI
https://doi.org/10.1371/journal.pone.0055435
Journal volume & issue
Vol. 8, no. 3
p. e55435

Abstract

Read online

Among approximately 1000 adenoviruses from chimpanzees and bonobos studied recently, the Pan Adenovirus type 3 (PanAd3, isolated from a bonobo, Pan paniscus) has one of the best profiles for a vaccine vector, combining potent transgene immunogenicity with minimal pre-existing immunity in the human population. In this study, we inserted into a replication defective PanAd3 a transgene expressing a fusion protein of conserved influenza antigens nucleoprotein (NP) and matrix 1 (M1). We then studied antibody and T cell responses as well as protection from challenge infection in a mouse model. A single intranasal administration of PanAd3-NPM1 vaccine induced strong antibody and T cell responses, and protected against high dose lethal influenza virus challenge. Thus PanAd3 is a promising candidate vector for vaccines, including universal influenza vaccines.